Business Standard

Wednesday, January 08, 2025 | 06:40 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Lupin Q2 net up 58% at Rs 662 cr

Consolidated total income jumps 29% to Rs 4,290 cr

Lupin receives US FDA for electrolyte replenisher

Press Trust of India New Delhi
Drug firm Lupin today reported a 57.75% rise in its consolidated net profit to Rs 662.19 crore for the second quarter ended September 30, mainly on account of robust sales.

The company had posted a net profit after taxes and minority interest of Rs 419.75 crore for the same period of the previous fiscal, Lupin said in a BSE filing.

Consolidated total income of the company also rose to Rs 4,290.51 crore during the quarter under consideration as against Rs 3,329.67 crore in the corresponding period last fiscal.

Shares of Lupin were trading 0.81% up at Rs 1,521.55 apiece on BSE.
 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 09 2016 | 3:20 PM IST

Explore News